The effect of antenatal steroids on metabolic bone disease of prematurity
Antenatal steroid administration did not significantly influence the diagnosis of metabolic bone disease when assessed using biochemical markers at four weeks of age. These findings underscore the importance of birth weight in the risk profile for metabolic bone disease while indicating that antenatal steroids are not a contributing factor.
Authors
- Sabriye Korkut (ORCID: https://orcid.org/0000-0003-4169-1912)
- Nihan Hilal Hoşağası (ORCID: https://orcid.org/0000-0002-2107-4485)
- Mustafa Şenol Akın (ORCID: https://orcid.org/0000-0003-0055-8277)
- Sara Erol (ORCID: https://orcid.org/0000-0002-8758-7662)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1515/jpem-2025-0033
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00